Urinary tract infection: Current management strategies

Postgraduate Medicine

Volumn 100, Issue 5, 1996, Pages

  Wisinger, David B ^a  

^a MARICOPA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMPICILLIN; AZTREONAM; CEFPODOXIME; CEFTRIAXONE; CIPROFLOXACIN; COTRIMOXAZOLE; ENOXACIN; GENTAMICIN; LOMEFLOXACIN; NITROFURANTOIN; NORFLOXACIN; OFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SULFAMETHOXAZOLE; TRIMETHOPRIM;

ASYMPTOMATIC BACTERIURIA; BACTERIAL VIRULENCE; CATHETER INFECTION; CYSTITIS; DISEASE PREDISPOSITION; DRUG COST; DRUG MIXTURE; ESCHERICHIA COLI; HOST RESISTANCE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MICROBIOLOGY; ORAL DRUG ADMINISTRATION; PYELONEPHRITIS; REVIEW; URINARY TRACT INFECTION;

EID: 10544239105     PISSN: 00325481     EISSN: None     Source Type: Journal    
DOI: 10.3810/pgm.1996.11.119     Document Type: Review

References (25)

1. Patton JP, Nash DB, Abrutyn E. Urinary tract infection: economic considerations. Med Clin North Am 1991;75(2):495-513
2. Johnson CC. Definitions, classification, and clinical presentation of urinary tract infections. Med Clin North Am 1991;75(2):241-52
3. Daifuku R, Stamm WE. Association of rectal and urethral colonization with urinary tract infection in patients with indwelling catheters. JAMA 1984;252(15):2028-30
4. Sobel JD. Bacterial etiologic agents in the pathogenesis of urinary tract infection. Med Clin North Am 1991;75(2):253-73
5. Schaeffer AJ, Schwan WR, Hultgren SJ, et al. Relationship of type 1 pilus expression in Escherichia coli to ascending urinary tract infections in mice. Infect Immun 1987;55(2):373-80
6. Orskov I, Ferencz A, Orskov F. Tamm-Horsfall protein or uromucoid is the normal urinary slime that traps type 1 fimbriated Escherichia coli. (Letter) Lancet 1980;1(8173):887
7. Sheinfeld J, Schaeffer AJ, Cordon-Cardo C, et al. Association of the Lewis blood-group phenotype with recurrent urinary tract infections in women. N Engl J Med 1989;320(12):773-7
8. Schaeffer AJ, Jones JM, Dunn JK. Association of vitro Escherichia coli adherence to vaginal and buccal epithelial cells with susceptibility of women to recurrent urinary-tract infections. N Engl J Med 1981;304(18): 1062-6
9. Parsons CL, Greenspan C, Malholland SG. The primary antibacterial defense mechanism of the bladder. Invest Urol 1975;13(1):72-8
10. Freedman LR, Beeson TB. Experimental pyelonephritis. IV. Observations on infections resulting from direct inoculation of bacteria in different zones of the kidney. Yale J Biol Med 1958;30:406-14
11. Rene P, Dinolfo M, Silverblatt FJ. Serum and urogenital antibody responses to Escherichia coli pili in cystitis. Infect Immun 1982;38(2): 542-7
12. Measley RE Jr, Levison ME. Host defense mechanisms in the pathogenesis of urinary tract infection. Med Clin North Am 1991;75(2): 275-86
13. Vejlsgaard R. Studies on urinary infection in diabetics. I. Bacteriuria in patients with diabetes mellitus and in control subjects. Acta Med Scand 1966;179(2):173-82
14. Bryan CS, Reynolds KL. Community-acquired bacteremic urinary tract infection: epidemiology and outcome. J Urol 1984;132(3):490-3
15. Bryan CS, Reynolds KL. Hospital-acquired bacteremic urinary tract infection: epidemiology and outcome. J Urol 1984;132(3):494-8
16. Stamm WE, Hooton TM. Management of urinary tract infections in adults. N Engl J Med 1993;329(18):1328-34
17. Fihn SD, Latham RH, Roberts P, et al. Association between diaphragm use and urinary tract infection. JAMA 1985;254(2):240-5
18. Strom BL, Collins M, West SL, et al. Sexual activity, contraceptive use, and other risk factors for symptomatic and asymptomatic bacteriuria: a case-control study. Ann Intern Med 1987;107(6):816-23
19. Stapleton A, Latham RH, Johnson C, et al. Postcoital antimicrobial prophylaxis for recurrent urinary tract infection: a randomized, double-blind, placebo-controlled trial. JAMA 1990;264(6):703-6
20. Harding GK, Ronald AR, Nicolle LE, et al. Long-term antimicrobial prophylaxis for recurrent urinary tract infection in women. Rev Infect Dis 1982;4(2):438-43
21. Raz R, Stamm WE. A controlled trial of intravaginal estriol in post-menopausal women with recurrent urinary tract infections. N Engl J Med 1993;329(11):753-6
22. Patterson JE, Andriole VT. Bacterial urinary tract infections in diabetes. Infect Dis Clin North Am 1995;9(1):25-51
23. Warren JW, Anthony WC, Hoopes JM, et al. Cephalexin for susceptible bacteriuria in afebrile, long-term catheterized patients. JAMA 1982;248(4):454-8
24. Zhanel GG, Harding GK, Guay DR. Asymptomatic bacteriuria: which patients should be treated? Arch Intern Med 1990;150(7):1389-96
25. Andriole VT, Patterson TF. Epidemiology, natural history, and management of urinary tract infections in pregnancy. Med Clin North Am 1991;75(2):359-73